Novo-backed BioClin Therapeutics will put the funding toward advancing an antibody it is developing as a metastatic bladder cancer treatment through phase 1b/2 trials.

Salesforce, SMBC, Mizuho Bank and Fukuoka Financial Group have backed asset management app developer Moneytree's series B round.

The fashion rental platform has received $20m in a series B round led by Pan-Lin Asset Management that included existing investor IDG Capital.

The vaccine developer has secured $64m, $60m of which came from a series B round led by Nan Fung-backed firm Pivotal BioVenture Partners and backed by Roche.

Johnson & Johnson and GlaxoSmithKline have contributed to a series B round for Pulmocide, a respiratory therapy spinout of Imperial College London.

Touchstone Innovations, which previously led a series A in 2013, has put $3.7m into the series B round and participated alongside several corporates such as GlaxoSmithKline.

Tokio Marine HCC and WR Berkley have funded a series B round for the weather prediction software developer, more than doubling its total funding to $30m.

The round was co-led by Evolution Media China, a unit of corporate-backed Evolution Media Partners that focuses on investments across Asia.

Suzhou Ribo Life Science, which is developing RNA therapies for hepatitis B, hyperlipidaemia and liver cancer, has secured funding in a Legend Capital-backed series B round.